
Pfizer and German partner BioNTech SE are the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine. The companies said they have so far found no serious safety concerns and expect to seek U.S. emergency use authorization later this month.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3kgpCpo
via
IFTTT
0 comments:
Post a Comment